ARCHIVES

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

This article is from The Cancer Letter archive.

Vol. 32 No. 01 | January 13, 2006

Download PDF Visit The Full Archive

Related Articles

NCI To Support Chemoprevention Grants In Tobacco-Related Cancer, Ex-Smokers.

March 16, 2001

California approves $3 billion program for stem-cell research.

November 5, 2004

As Avastin Decision Nears, Patient Groups Split On PFS In Front Line Breast Cancer.

February 22, 2008

Blackburn Wins BMS Award

May 23, 2003

ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.

May 18, 2001

NTP Board Approves Six New Projects, Tables One Other

January 23, 1981